News

Sitagliptin inhibits plasma DPP-4 activity in a dose-dependent manner. [12] After an oral glucose load or a meal, sitagliptin increases circulating levels of active GLP-1 and GIP by two-to ...
REDWOOD CITY, Calif., July 01, 2025 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (Soleno) (NASDAQ: SLNO), a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, ...
Sitagliptin is a new oral agent approved by the FDA to treat patients with type 2 diabetes who have inadequate glycemic control on diet and exercise or on pioglitazone or metformin monotherapy.
Viture Pro XR Glasses Work On Switch 2 - Save $100, Get Free 8BitDo Controller These high-tech extended reality glasses are compatible with smartphones, PC, Steam Deck, and game consoles.
Xeljanz is a prescription drug used to treat rheumatoid arthritis and other autoimmune conditions. Learn about possible side effects and how to manage them.
Ozempic/Wegovy is the first drug on HHS's 2025 list of Medicare price negotiations. As the leaders of the pharmaceutical industry boarded their planes to come home from the JP Morgan Healthcare ...
Discover the serious yet rare side effects of Ozempic, including pancreatitis, thyroid cancer, gallbladder issues, kidney injury, and allergic reactions, plus expert insights.
The RayNeo Air 3S is available for $269 These XR glasses provide advanced micro-OLED screens, dual speaker chamber design, and a 201-inch screen visual experience There are no light-blocking ...